相关临床试验
0
0 进行中
药物批准
3
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
<p><strong>4.1 Therapeutic indications</strong></p> <p>TEPADINA is indicated, in combination with other chemotherapy medicinal products:</p> <ul> <li>with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;</li> <li>when high dose chemotherapy with HPCT support is appropriate for the treatment of breast cancer in adult patients and CNS tumours in paediatric patients.</li> </ul>
<p><strong>4.1 Therapeutic indications</strong></p> <p>Treatment of primary apnoea of premature newborns.</p>
**4.1 Therapeutic indications** TEPADINA is indicated, in combination with other chemotherapy medicinal products: - with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; - when high dose chemotherapy with HPCT support is appropriate for the treatment of breast cancer in adult patients and CNS tumours in paediatric patients.
暂无资讯文章
